| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 746035 | 2-4-[(5-2,6-dimethoxy-4-[5-(3,4,5-trimethoxyphenyl)-4,5-dihydro-3-isoxazolyl]phenoxypentyl)oxy]-3-methoxyphenyl-1,2,3,4-tetrahydro-4-quinazolinone | 0.0382675857669585 | 0.06426202 |
| NSC 747556 | 6-(4'-Hydroxy-2'-methylphenyl)-2-benzenesulfonamide-4,5-dihydropyridazine-3(2H)-one | 0.0382675857669585 | 0.37954839 |
| NSC 750743 | (E)-3-(6-(thiophen-2-yl)imidazo[2,1-b]thiazol-5-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one | 0.0382675857669585 | 0.37572839 |
| NSC 755469 | Null | 0.0382675857669585 | 0.32719114 |
| NSC 757982 | Null | 0.0382675857669585 | 0.57618794 |
| NSC 9598 | 3-(Dimethylamino)-7-(methylimino)-3H-phenothiazine hydrochloride | 0.0382675857669585 | 0.27018217 |
| NSC 10848 | Null | 0.0382675857669588 | 0.026325097 |
| NSC 173516 | 1,3,5-Triazine-2,4-diamine, 1-[4-fluoro-3-(trifluoromethyl)phenyl]-1,6-dihydro-6,6-dimethyl-, monohydrochloride | 0.0382675857669588 | 0.51829269 |
| NSC 221266 | Benzoic acid, 3,4-dichloro-, [1-[4-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl]ethylidene]hydrazide, monohy | 0.0382675857669588 | 0.38769022 |
| NSC 224131 | N-Phosphonacetyl-L-aspartate | 0.0382675857669588 | 0.5486452 |